Institutional investors hold a majority ownership of MRK through the 75.74% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2016, these large investors purchased a net $15.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BMO ASSET MANAGEMENT CORP. Bought 2.8 Million shares of Merck
STATE STREET GLOBAL ADVISORS LTD... Bought 1.4 Million shares of Merck
COLUMBUS CIRCLE INVESTORS Bought 1.1 Million shares of Merck